Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

24.62
Delayed Data
As of 3:59pm ET
 +0.55 / +2.29%
Today’s Change
17.92
Today|||52-Week Range
44.48
-18.45%
Year-to-Date
No recent news for AMAG Pharmaceuticals Inc.

Today’s Trading

Previous close24.07
Today’s open24.15
Day’s range23.98 - 24.66
Volume334,534
Average volume (3 months)850,590
Market cap$822.1M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-82.73%
Earnings growth (this year)+477.30%
Earnings growth (next 5 years)-0.61%
Revenue growth (last year)+236.28%
P/E ratioNM
Price/Sales2.55
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-0.12-0.54%
MNTAMomenta Pharmaceutic...+0.22+1.89%
ANIPANI Pharmaceuticals ...+2.90+4.44%
BPMCBlueprint Medicines ...+0.35+1.28%
Data as of 4:00pm ET, 09/27/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$1.44
Annual revenue (last year)$418.3M
Annual profit (last year)$32.8M
Net profit margin7.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts

Search for Jobs